Related Experiment Video
Updated: Jul 30, 2026

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma DIPG
Published on: March 7, 2017
A systematic review of adult pineoblastoma
Xiufeng Chu1,2, Ting Zhang1, Helen Benghiat3
1Department of Oncology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Background:
Adult pineoblastoma is an extremely rare central nervous system malignancy. Limitations of tumour databases, single institution retrospective analyses and a few case reports are not sufficient to clarify treatment options. Therefore, a systematic review of comprehensive research data provides referenceable treatment options.
Methods:
A systematic review was performed using MEDLINE and Embase using the terms "pineoblastoma" and "adult". Relevant articles in the references were considered to supplement this systematic review. In addition, data were analysed using Kaplan-Meier survival curves, COX analysis, chi-square tests and log-rank tests.
Results:
A total of 108 adult cases from 32 articles were included in this study and the median age at diagnosis was 30 years. The 5-year survival rate was 49.5% (95% confidence interval: 0.378-0.602) and the 10-year survival rate was 33.9% (95% confidence interval: 0.207-0.476). During the 10-year follow-up period, Kaplan-Meier survival curves highlighted that the gross total resection was more beneficial than subtotal resection and no surgery (P=0.018). The treatment modality of radiotherapy and chemotherapy was beneficial for survival (P<0.001; P=0.020). In addition, multivariate COX analysis showed that radiotherapy was an independent factor in the beneficial prognosis (P<0.001) and gross total resection tends to improve survival within five years (P=0.079).
Conclusion:
For adult pineoblastoma, gross total excision and radiotherapy can be beneficial for survival.Systematic Review Registration: [website], identifier [registration number].
Insights
This systematic review found that gross total resection and radiotherapy significantly improve survival rates for adult pineoblastoma patients. These findings offer crucial guidance for treating this rare central nervous system malignancy.
Area of Science:
- Neuro-oncology
- Neurosurgery
- Radiation Oncology
Background:
- Adult pineoblastoma is an extremely rare central nervous system (CNS) malignancy.
- Existing data from tumour databases and single-institution studies are insufficient to guide treatment decisions.
- A systematic review is necessary to consolidate research and provide evidence-based treatment options.
Purpose of the Study:
- To systematically review existing research data on adult pineoblastoma.
- To identify effective treatment strategies and prognostic factors for adult pineoblastoma.
- To provide referenceable treatment options for this rare CNS malignancy.
Main Methods:
- A systematic literature search was conducted using MEDLINE and Embase with terms "pineoblastoma" and "adult".
- Relevant articles and their references were reviewed to supplement the systematic search.
- Data were analyzed using Kaplan-Meier survival curves, COX analysis, chi-square tests, and log-rank tests.
Main Results:
- The study included 108 adult cases from 32 articles, with a median age of 30 years.
- Five-year and 10-year survival rates were 49.5% and 33.9%, respectively.
- Gross total resection (P=0.018), radiotherapy (P<0.001), and chemotherapy (P=0.020) were associated with improved survival. Radiotherapy was an independent prognostic factor (P<0.001).
Conclusions:
- Gross total excision and radiotherapy demonstrate significant benefits for improving survival in adult pineoblastoma.
- These findings underscore the importance of aggressive surgical resection and adjuvant radiotherapy in managing adult pineoblastoma.
- Further research may refine treatment protocols for this rare CNS tumor.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

